Profil

Sautois Brieuc

Département des sciences cliniques

See author's contact details
ORCID
0000-0002-0029-7735
Main Referenced Co-authors
Fillet, Georges  (34)
Jerusalem, Guy  (23)
Beguin, Yves  (18)
Gennigens, Christine  (13)
Polus, Marc  (11)
Main Referenced Keywords
Humans (23); Male (15); Female (11); Adult (10); Middle Aged (10);
Main Referenced Disciplines
Oncology (42)
Hematology (28)
Endocrinology, metabolism & nutrition (2)
Radiology, nuclear medicine & imaging (2)
Gastroenterology & hepatology (1)

Publications (total 72)

The most downloaded
6084 downloads
PIRET, P., WERENNE, X., Sautois, B., Demez, P., & Coucke, P. (2014). EXPLORATION ET TRAITEMENT D’UN CARCINOME EPIDERMOIDE GANGLIONNAIRE CERVICAL SANS PRIMITIF DECELE. Revue Médicale de Liège, 69 (Supp 1), 58-62. https://hdl.handle.net/2268/165558

The most cited

411 citations (Scopus®)

Abida, W., Patnaik, A., Campbell, D., Shapiro, J., Bryce, A. H., McDermott, R., Sautois, B., Vogelzang, N. J., Bambury, R. M., Voog, E., Zhang, J., Piulats, J. M., Ryan, C. J., Merseburger, A. S., Daugaard, G., Heidenreich, A., Fizazi, K., Higano, C. S., Krieger, L. E., ... Chowdhury, S. A. (2020). Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration. Journal of Clinical Oncology, 38 (32), 3763-3772. doi:10.1200/JCO.20.01035 https://hdl.handle.net/2268/250228

The most significant

Fizazi, K., Piulats, J. M., Reaume, M. N., Ostler, P., McDermott, R., Gingerich, J. R., Pintus, E., Sridhar, S. S., Bambury, R. M., Emmenegger, U., Lindberg, H., Morris, D., Nolè, F., Staffurth, J., Redfern, C., Sáez, M. I., Abida, W., Daugaard, G., Heidenreich, A., ... TRITON3 Investigators. (23 February 2023). Rucaparib or Physician's Choice in Metastatic Prostate Cancer. New England Journal of Medicine, 388 (8), 719 - 732. doi:10.1056/NEJMoa2214676
Peer Reviewed verified by ORBi

Denis, C., COUSIN, F., De Laere, B., HUSTINX, R., SAUTOIS, B.* , & WITHOFS, N.*. (21 April 2022). Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice. Journal of Nuclear Medicine, 63 (12), 1815-1821. doi:10.2967/jnumed.121.263611
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Sautois, B., Loehr, A., Watkins, S. P., SCHROEDER, H., & Abida, W. (2022). A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B Alteration. Current Oncology, 29 (6), 4178-4184. doi:10.3390/curroncol29060333
Peer Reviewed verified by ORBi

Martin, M., & SAUTOIS, B. (January 2021). Early onset of head and neck squamous-cell carcinoma and fatal toxicity with concurrent chemoradiotherapy in a patient compound heterozygote for FANCA gene [letter to the editor]. Oral Oncology, 112, 104989. doi:10.1016/j.oraloncology.2020.104989
Peer Reviewed verified by ORBi

Abida, W., Campbell, D., Patnaik, A., Shapiro, J. D., Sautois, B., Vogelzang, N. J., Voog, E. G., Bryce, A. H., McDermott, R., Ricci, F., Rowe, J., Zhang, J., Piulats, J. M., Fizazi, K., Merseburger, A. S., Higano, C. S., Krieger, L. E., Ryan, C. J., Feng, F. Y., ... Chowdhury, S. (2020). Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: analysis from the phase 2 TRITON2 study. Clinical cancer research : an official journal of the American Association for Cancer Research, 26 (11), 2487-2496. doi:10.1158/1078-0432.CCR-20-0394
Peer reviewed


Denis, C., & Sautois, B. (November 2023). Mise au point et stratégies thérapeutiques dans le cancer de la prostate avancé et métastatique. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 47 (6), 300 - 308. doi:10.1016/j.mednuc.2023.09.003
Editorial reviewed

Abida, W., Campbell, D., Patnaik, A., Bryce, A. H., Shapiro, J., Bambury, R. M., Zhang, J., Burke, J. M., Castellano, D., Font, A., Ganju, V., Hardy-Bessard, A.-C., McDermott, R., Sautois, B., Spaeth, D., Voog, E., Piulats, J. M., Pintus, E., Ryan, C. J., ... Chowdhury, S. (03 June 2023). Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study. European Urology, 84 (3), 321-330. doi:10.1016/j.eururo.2023.05.021
Peer Reviewed verified by ORBi

Fizazi, K., Piulats, J. M., Reaume, M. N., Ostler, P., McDermott, R., Gingerich, J. R., Pintus, E., Sridhar, S. S., Bambury, R. M., Emmenegger, U., Lindberg, H., Morris, D., Nolè, F., Staffurth, J., Redfern, C., Sáez, M. I., Abida, W., Daugaard, G., Heidenreich, A., ... TRITON3 Investigators. (23 February 2023). Rucaparib or Physician's Choice in Metastatic Prostate Cancer. New England Journal of Medicine, 388 (8), 719 - 732. doi:10.1056/NEJMoa2214676
Peer Reviewed verified by ORBi

Loehr, A., Hussain, A., Patnaik, A., Bryce, A. H., Castellano, D., Font, A., Shapiro, J., Zhang, J., Sautois, B., Vogelzang, N. J., Chatta, G., Courtney, K., Harzstark, A., Ricci, F., Despain, D., Watkins, S., King, C., Nguyen, M., Simmons, A. D., ... Abida, W. (2023). Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. European Urology, 83 (3), 200-209. doi:10.1016/j.eururo.2022.09.010
Peer Reviewed verified by ORBi

Verdonck Beatove, E., Piette, C., Sautois, B., & Gennigens, C. (2023). Late metastatic relapse of an initially bifocal intracranial germ cell tumor with modestly elevated tumor markers: A case report [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium.
Peer reviewed

Denis, C., COUSIN, F., De Laere, B., HUSTINX, R., SAUTOIS, B.* , & WITHOFS, N.*. (21 April 2022). Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice. Journal of Nuclear Medicine, 63 (12), 1815-1821. doi:10.2967/jnumed.121.263611
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Sautois, B., Loehr, A., Watkins, S. P., SCHROEDER, H., & Abida, W. (2022). A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B Alteration. Current Oncology, 29 (6), 4178-4184. doi:10.3390/curroncol29060333
Peer Reviewed verified by ORBi

Sautois, B., & Denis, C. (2022). Le médicament du mois : Apalutamide, Erleada® (2022). Revue Médicale de Liège, 77 (10), 609-615.
Editorial Reviewed verified by ORBi

ONESTI, C. E., Schroeder, H., Rorive, A., Sautois, B., Lecocq, M., Goffin, M., Gonne, E., Collinge, A., Nicolaers, L., Wéra, O., Catot, A., Loly, C., Paulus, A., Sibille, A., Lousberg, L., Troisfontaine, F., Collignon, J., Gennigens, C., Frères, P., ... Jerusalem, G. (2021). Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study. Cancer Reports, 1571. doi:10.1002/cnr2.1571
Peer reviewed

Colassin, A., Denis, C., HERMESSE, J., WALTREGNY, D., & SAUTOIS, B. (May 2021). Prise en charge d'un cancer de la prostate métastatique au diagnostic. Revue Médicale de Liège, 76 (5-6), 496-501.
Peer reviewed

Denis, C., Sakalihasan, S., FRERES, P., WITHOFS, N., & SAUTOIS, B. (2021). Cemiplimab for cisplatin resistant metastatic penile cancer. Case Reports in Oncology, 14, 972-976. doi:10.1159/000517008
Peer Reviewed verified by ORBi

Lambert, E., Hollebosch, S., van Praet, C., Van Bruwaene, S., Duck, L., De Roock, W., van Wambeke, S., Ghysel, C., Ameye, F., Schatteman, P., Vandenbroucke, F., Sautois, B., Baekelandt, F., Ost, D., Fransis, K., Filleul, B., Remondo, C., Wynendaele, W., Bamelis, B., ... Lumen, N. (2021). Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis. Acta Clinica Belgica, 1-9. doi:10.1080/17843286.2021.2001999
Peer Reviewed verified by ORBi

Loehr, A., Patnaik, A., Campbell, D., Shapiro, J., Bryce, A. H., McDermott, R., Sautois, B., Vogelzang, N. J., Bambury, R. M., Voog, E., Zhang, J., Piulats, J. M., Hussain, A., Ryan, C. J., Merseburger, A. S., Daugaard, G., Heidenreich, A., Fizazi, K., Higano, C. S., ... Abida, W. (2021). Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study. Clinical Cancer Research, 27 (24), 6677-6686. doi:10.1158/1078-0432.CCR-21-2199
Peer Reviewed verified by ORBi

Martinez Chanza, N., Soukane, L., Barthelemy, P., Carnot, A., Gil, T., Casert, V., Vanhaudenarde, V., Sautois, B., Staudacher, L., Van den Brande, J., Culine, S., Seront, E., Gizzi, M., Albisinni, S., Tricard, T., Fantoni, J. C., Paesmans, M., Caparica, R., Roumeguere, T., & Awada, A. (2021). Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial). BMC Cancer, 21 (1), 1292. doi:10.1186/s12885-021-08990-3
Peer Reviewed verified by ORBi

Lecocq, M., Poncin, A., & Sautois, B. (2021). Place de l’immunothérapie dans le traitement des carcinomes épidermoïdes de la tête et du cou. Revue Médicale de Liège, 76 (5-6), 398-402.
Peer reviewed

Martin, M., & SAUTOIS, B. (January 2021). Early onset of head and neck squamous-cell carcinoma and fatal toxicity with concurrent chemoradiotherapy in a patient compound heterozygote for FANCA gene [letter to the editor]. Oral Oncology, 112, 104989. doi:10.1016/j.oraloncology.2020.104989
Peer Reviewed verified by ORBi

LECOCQ, M., ONESTI, C. E., SCHROEDER, H., RORIVE, A., Goffin, M., GONNE, E., SAUTOIS, B., Catot, A., WERA, O., NICOLAERS, L., COLLINGE, A., Collignon, J., FRERES, P., POLUS, M., DUYSINX, B., VAILLANT, F., GENNIGENS, C., MARCHAL, N., PONCIN, A., & JERUSALEM, G. (2020). Risk of SARS-CoV-2 infection and outcome after infection : Experience from the day-care unit at CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain.

Abida, W., Patnaik, A., Campbell, D., Shapiro, J., Bryce, A. H., McDermott, R., Sautois, B., Vogelzang, N. J., Bambury, R. M., Voog, E., Zhang, J., Piulats, J. M., Ryan, C. J., Merseburger, A. S., Daugaard, G., Heidenreich, A., Fizazi, K., Higano, C. S., Krieger, L. E., ... Chowdhury, S. A. (2020). Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration. Journal of Clinical Oncology, 38 (32), 3763-3772. doi:10.1200/JCO.20.01035
Peer reviewed

ONESTI, C. E., SCHROEDER, H., RORIVE, A., SAUTOIS, B., LECOCQ, M., Goffin, M., GONNE, E., COLLINGE, A., NICOLAERS, L., WERA, O., Catot, A., LOLY, C., PAULUS, A., SIBILLE, A., LOUSBERG, L., Troisfontaine, F., COLLIGNON, J., GENNIGENS, C., FRERES, P., & JERUSALEM, G. (2020). How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain.

Abida, W., Campbell, D., Patnaik, A., Shapiro, J. D., Sautois, B., Vogelzang, N. J., Voog, E. G., Bryce, A. H., McDermott, R., Ricci, F., Rowe, J., Zhang, J., Piulats, J. M., Fizazi, K., Merseburger, A. S., Higano, C. S., Krieger, L. E., Ryan, C. J., Feng, F. Y., ... Chowdhury, S. (2020). Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: analysis from the phase 2 TRITON2 study. Clinical cancer research : an official journal of the American Association for Cancer Research, 26 (11), 2487-2496. doi:10.1158/1078-0432.CCR-20-0394
Peer reviewed

Hakenberg, O. W., Perez-Gracia, J. L., Castellano, D., Demkow, T., Ali, T., Caffo, O., Heidenreich, A., Schultze-Seemann, W., Sautois, B., Pavlik, I., Qin, A., Novosiadly, R. D., Shahir, A., Ilaria, R. J., & Nippgen, J. (2019). Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. European journal of cancer (Oxford, England : 1990), 107, 186-195. doi:10.1016/j.ejca.2018.10.005
Peer reviewed

SAUTOIS, B., SCHROEDER, H., MARTIN, M., PIRET, P., DEMEZ, P., BOUCHAIN, O., MUTIJIMA NZARAMBA, E., & MOREAU, P. (2016). Weekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma. Journal of Balkan Union of Oncology, 21 (4), 979-988.
Peer Reviewed verified by ORBi

Seront, E., Rottey, S., Filleul, B., Glorieux, P., Goeminne, J., Verschaeve, V., Vandenbulcke, J.-M., Sautois, B., Boegner, P., Gillain, A., van Maanen, A., & Machiels, J.-P. (2016). Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma (TCC). BJU International. doi:10.1111/bju.13415
Peer Reviewed verified by ORBi

Machiels, J.-P. H., Van Maanen, A., Vandenbulcke, J.-M., Filleul, B., Seront, E., Henry, S., D'Hondt, L., Lonchay, C., Holbrechts, S., Boegner, P., Brohee, D., Dequanter, D., Louviaux, I., Sautois, B., Whenham, N., Berchem, G., Vanderschueren, B., Fontaine, C., Schmitz, S., ... Rottey, S. (2016). Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy. Oncologist, 21, 1-10. doi:10.1634/theoncologist.2016-0296
Peer Reviewed verified by ORBi

PIRET, P., WERENNE, X., Sautois, B., Demez, P., & Coucke, P. (2014). EXPLORATION ET TRAITEMENT D’UN CARCINOME EPIDERMOIDE GANGLIONNAIRE CERVICAL SANS PRIMITIF DECELE. Revue Médicale de Liège, 69 (Supp 1), 58-62.
Peer reviewed

Sautois, B., & GENNIGENS, C. (2013). Actualites therapeutiques dans le traitement medical du cancer de la prostate resistant a la castration. Revue Médicale de Liège, 68 (2), 94-6.
Peer reviewed

Seront, E., Rottey, S., Sautois, B., Kerger, J., D'Hondt, L. A., Verschaeve, V., Canon, J.-L., Dopchie, C., Vandenbulcke, J. M., Whenham, N., Goeminne, J. C., Clausse, M., Verhoeven, D., Glorieux, P., Branders, S., Dupont, P., Schoonjans, J., Feron, O., & Machiels, J.-P. (2012). Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers. Annals of Oncology, 23 (10), 2663-70. doi:10.1093/annonc/mds057
Peer Reviewed verified by ORBi

PHAN BA, R., BELACHEW, S., JEDIDI, Z., SAUTOIS, B., DEPREZ, M., & MOONEN, G. (May 2011). Radiation-induced malignant peripheral nerve sheat tumors – a report of 2 cases [Poster presentation]. European Neurological Society 21st Meeting, Lisbon, Portugal.

Martin, M., Demez, P., MOREAU, P., Devillers, D., PIRET, P., & Sautois, B. (January 2010). Chimiothérapie néoadjuvante dans les cancers "tête et cou". Revue Médicale de Liège, 65 (1), 15-17.
Peer reviewed

Gennigens, C., Sautois, B., & Jerusalem, G. (2010). Le medicament du mois. Everolimus (RAD001/Afinitor) dans le traitement du cancer du rein métastatique. Revue Médicale de Liège, 65 (4), 212-6.
Peer reviewed

Mievis, C., Jansen, N., Schleich, F., Gennigens, C., Rorive, A., Jerusalem, G., Fillet, G., & Sautois, B. (2009). Le cas clinique du mois. Reaction de rappel d'irradiation induite par l'administration de cyclophosphamide. Revue Médicale de Liège, 64 (4), 179-81.
Peer reviewed

Gennigens, C., Collignon, J., Jerusalem, G., Rorive, A., & Sautois, B. (2009). Anticorps monoclonaux a usage therapeutique en hemato-oncologie. Generalites. Revue Médicale de Liège, 64 (5-6), 264-7.
Peer reviewed

Gennigens, C., Kridelka, F., Jerusalem, G., & Sautois, B. (2009). Ovariumkanker : nieuwe cytotoxica en ontwikkeling van gerichte therapieën. Gunaïkeia. Koninklijke Belgische Vereniging voor Gynecologie en Verloskunde, 14 (6), 174-190.
Peer reviewed

Sautois, B., Martin, M., Demez, P., Piret, P., Devillers, D., & Moreau, P. (2009). Place des anticorps monoclonaux dans le traitement des tumeurs de la tete et du cou. Revue Médicale de Liège, 64 (5-6), 284-6.
Peer reviewed

Coucke, P., Piret, P., Werenne, X., Demez, P., Sautois, B., & Moreau, P. (2008). Les tumeurs de la sphere ORL: standards de traitement et nouvelles approches en radiothérapie. Revue Médicale de Liège, 63 (3), 141-8.
Peer reviewed

Paulus, A., Gennigens, C., Fillet, G., Loly, C., & Sautois, B. (September 2007). Traitement chimiothérapique actuel du cancer de l'ovaire. Revue Médicale de Liège, 62 (9), 539-47.
Peer reviewed

Jerusalem, G., Rorive, A., Gennigens, C., Sautois, B., Mievis, C., & Fillet, G. (2007). Actualités thérapeutiques en oncologie sénologique: place actuelle et perspectives des traitements cibles. Revue Médicale de Liège, 62 Spec No, 2-5.
Peer reviewed

Gennigens, C., Sautois, B., Rorive, A., Fillet, G., & Jerusalem, G. (2007). Actualites therapeutiques en oncologie: l'essor des therapeutiques ciblees. Revue Médicale de Liège, 62 (5-6, May-Jun), 391-8.
Peer reviewed

Smeets, L., De Roover, A., & Sautois, B. (2006). Le cas clinique du mois. Recidive d'une tumeur testiculaire mixte 15 ans apres le traitement initial. Revue Médicale de Liège, 61 (10), 671-4.
Peer reviewed

Wauters, O., Sautois, B., & Fillet, G. (2005). L'image du mois. Une image de "lâcher de ballons" à l'imagerie thoracique. Revue Médicale de Liège, 60, 909.
Peer reviewed

Polus, M., Piront, P., Jerusalem, G., Sautois, B., Defechereux, T., de Leval, L., & Fillet, G. (February 2004). L'image du mois. Tumeur de Merkel : reponse majeure a la chimiotherapie. "Il n'y a pas que la neige qui fond au soleil". Revue Médicale de Liège, 59 (2), 67-8.
Peer reviewed

Gillain, S., Gennigens, C., Sautois, B., Polus, M., Bonnet, C., Fillet, G., & Jerusalem, G. (2004). Traitement du cancer du sein chez la personne âgée. Revue Médicale Suisse, 62, 1618-21.
Peer Reviewed verified by ORBi

Polus, M., Piront, P., Jerusalem, G., Sautois, B., Louis, E., Detroz, B., Laurent, S., Belaiche, J., & Fillet, G. (April 2003). Prevention primaire et secondaire du cancer colorectal. Revue Médicale de Liège, 58 (4), 247-53.
Peer reviewed

Hustinx, R., Sautois, B., Jerusalem, G., & Foidart, J. (2003). Radiothérapie métabolique des douleurs osseuses métastatiques. Médecine et Hygiène, 61, 1560-1564.
Peer Reviewed verified by ORBi

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.
Peer Reviewed verified by ORBi

Polus, M., Honore, P., De Roover, A., Detry, O., Detroz, B., Jerusalem, G., Sautois, B., & Fillet, G. (December 2002). La carcinomatose hepatique du cancer colorectal: actualites therapeutiques. Revue Médicale de Liège, 57 (12), 771-8.
Peer reviewed

Pelerin, D., Silvestre, R. M., Jerusalem, G., Sautois, B., Polus, M., & Fillet, G. (December 2002). Comment je traite ... par hormonotherapie des patientes developpant des complications thrombo-emboliques lors du traitement d'un cancer du sein par tamoxifene. Revue Médicale de Liège, 57 (12), 755-6.
Peer reviewed

Polus, M., Bours, V., Jerusalem, G., Sautois, B., & Fillet, G. (July 2002). Comment je traite.... Le cancer avance du pancreas par une approche innovante dirigee contre les nouvelles cibles. Revue Médicale de Liège, 57 (7), 428-32.
Peer reviewed

Polus, M., Jerusalem, G., Sautois, B., Silvestre, R. M., & Fillet, G. (March 2002). Comment je traite.... Un cancer du pancreas avance. Revue Médicale de Liège, 57 (3), 131-4.
Peer reviewed

Polus, M., Jerusalem, G., Sautois, B., Silvestre, R. M., Collette, M. Y., Closon, M. T., & Fillet, G. (February 2002). Etude clinique du mois. Radio-chimiotherapie et chimiotherapie adjuvante apres resection a visee curative du cancer du pancreas: resultats de l'etude randomisee ESPAC-1. Revue Médicale de Liège, 57 (2), 119-22.
Peer reviewed

SAUTOIS, B. (2002). Contribution à l'étude des greffes de cellules souches du sang périphérique [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/245949

Brasseur, E., Silvestre, R.-M., Jerusalem, G., Sautois, B., Polus, M., & Fillet, G. (2002). Prévention et traitement des nausées et vomissements après chimiothérapie anticancéreuse. Médecine et Hygiène, 60, 1509-1513.
Peer Reviewed verified by ORBi

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6
Peer reviewed

Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346.
Peer reviewed

Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609.
Peer Reviewed verified by ORBi

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.
Peer Reviewed verified by ORBi

Scerbo, F., Matus, G., Sautois, B., & Fillet, G. (November 2000). Comment je traite ... le myelome multiple refractaire par thalidomide. Revue Médicale de Liège, 55 (11), 970-3.
Peer reviewed

Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634.
Peer Reviewed verified by ORBi

Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x
Peer Reviewed verified by ORBi

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.
Peer Reviewed verified by ORBi

Smitz, S., Neven, I., Sautois, B., & Tassin, F. (1999). L'image du mois. Purpura thrombocytopenique auto-immun. Revue Médicale de Liège, 54 (8), 645.
Peer reviewed

Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x
Peer Reviewed verified by ORBi

Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8.
Peer reviewed

Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75
Peer Reviewed verified by ORBi

Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1995). Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. British Journal of Haematology, 89 (1), 17-23. doi:10.1111/j.1365-2141.1995.tb08916.x
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1994). Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. European Journal of Haematology, 53 (5), 265-70. doi:10.1111/j.1600-0609.1994.tb01318.x
Peer Reviewed verified by ORBi

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1993). Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood, 82 (7), 2010-6. doi:10.1182/blood.v82.7.2010.bloodjournal8272010
Peer Reviewed verified by ORBi

Grek, V., BEGUIN, Y., Weber, G., Sautois, B., PAQUOT, N., SCHEEN, A., Lefebvre, P., & FILLET, G. (1992). Acute functional iron deficiency in obese subjects during very-low-energy all- protein diet [Poster presentation]. 24th Congress of The International Society of Haematology, London, United Kingdom.

Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045.
Peer Reviewed verified by ORBi

Sautois, B., Mélon, P., Grek, V., Fassotte, M.-F., & Fillet, G. (1991). Thrombocytopénie allergique à la nitrofurantoïne. Revue Médicale de Liège, 46, 592.
Peer reviewed

Contact ORBi